OP
hVIVO plc
OPORF · OTC
$0.11 +0.00% (+$0.00)
Market Cap £56.5M
P/E Ratio -
Div. Yield -
ROE 14.53%
Bulios Fair Price
$0.15
36.9% upside
Trenutna cena
$0.11
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica OPORF trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
4/9Valuation
75 /100
Cheap P/S 1.21x
P/B 1.48x
EV/EBITDA 13.23x
Growth
28 /100
Declining Book val. growth 23.57%
Rev. growth 2.65%
FCF growth N/A
Profitability
0 /100
Weak Net margin 12.81%
Op. margin 0.75%
FCF margin 31.64%
Quality
8 /100
Poor ROE 14.53%
ROA 8.35%
Asset turnover 0.65x
Debt
75 /100
Low Current ratio 1.63x
Int. coverage -0.29x
Net debt/EBITDA 0.11x
Stability
21 /100
Unstable Rev. volatility 21.19%
EPS volatility 1,244.77%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o OPORF
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Yamin Mohammed Khan
Employees
376
Headquarters
London
Prihajajoči dogodki
14 APR.
Earnings
Upcoming earnings report